Cargando…
ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance
ARID1A is a tumor suppressor gene mutated in 7–10% of pancreatic cancer patients. However, its function in pancreas development and endocrine regulation is unclear. We generated mice that lack Arid1a expression in the pancreas. Our results showed that deletion of the Arid1a gene in mice caused a red...
Autores principales: | Kuo, Tzu-Lei, Cheng, Kuang-Hung, Chen, Li-Tzong, Hung, Wen-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840936/ https://www.ncbi.nlm.nih.gov/pubmed/36654862 http://dx.doi.org/10.1016/j.isci.2022.105881 |
Ejemplares similares
-
Deciphering The Potential Role of Hox Genes in Pancreatic Cancer
por: Kuo, Tzu-Lei, et al.
Publicado: (2019) -
β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
por: Kuo, Tzu-Lei, et al.
Publicado: (2019) -
The Developmental Regulator Pax6 Is Essential for Maintenance of Islet Cell Function in the Adult Mouse Pancreas
por: Hart, Alan W., et al.
Publicado: (2013) -
Nesidioblastoma. Islet Cell Tumour of Pancreas
por: Stevenson, Douglas S., et al.
Publicado: (1942) -
Loss of FTO Antagonises Wnt Signaling and Leads to Developmental Defects Associated with Ciliopathies
por: Osborn, Daniel P. S., et al.
Publicado: (2014)